Premature heart disease mortality among US adults aged 25-64 decreased by 70% since 1968 but stagnated after 2011, with 2017 rates remaining 134% higher in men and 87% higher in Black individuals.
Observational
Despite historical declines, premature heart disease mortality in the US has stagnated since 2011, highlighting the need to address persistent demographic disparities and rising cardiometabolic risk factors.
Despite the premature heart disease mortality rate among adults aged 25-64 decreasing by 70% since 1968, the rate has remained stagnant from 2011 on and, in 2017, still accounted for almost 1-in-5 of all deaths among this age group. Moreover, these overall findings mask important differences and continued disparities observed by demographic characteristics and geography. For example, in 2017, rates were 134% higher among men compared to women and 87% higher among blacks compared to whites, and, while the greatest burden remained in the southeastern US, almost two-thirds of all US counties experienced increasing rates among adults aged 35-64 during 2010-2017. Continued high rates of uncontrolled blood pressure and increasing prevalence of diabetes and obesity pose obstacles for re-establishing a downward trajectory for premature heart disease mortality; however, proven public health and clinical interventions exist that can be used to address these conditions.
Ritchey et al. (Fri,) conducted a observational in Premature heart disease. Premature heart disease mortality among US adults aged 25-64 decreased by 70% since 1968 but stagnated after 2011, with 2017 rates remaining 134% higher in men and 87% higher in Black individuals.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: